Genprex, Inc. 8-K Filing Report: Key Insights from January 2025
Based on the provided section of the financial report, here are the key pieces of information extracted:
- Entity Information:
- Name: Genprex, Inc.
- State of Incorporation: Delaware (DE)
- CIK (Central Index Key): 0001595248
- IRS Employer Identification Number: 90-0772347
- Address: 3300 Bee Cave Road #650-227, Austin, TX 78746
- Phone Number: 512-537-7997
- Filing Details:
- Filing Type: 8-K (Current Report)
- Filing Date: January 13, 2025
- EDGAR Accession Number: Not provided in this excerpt.
- Stock Information:
- Common Stock: Yes
- Ticker Symbol: GNPX
- Exchange: NASDAQ
- Reporting Period:
- Start Date: January 13, 2025
- End Date: January 13, 2025
- XML/XBRL Context:
- The report structure follows XBRL (eXtensible Business Reporting Language), which is a format used for electronic submission of financial statements to the SEC.
Insights:
- The filing indicates that Genprex, Inc. is reporting significant information on January 13, 2025, which could be related to corporate events, financial results, or other material changes.
- The use of an 8-K form suggests that the company is disclosing an event that is of importance to shareholders and the market.
- The company is publicly traded on NASDAQ, indicating that it is subject to regulatory scrutiny and must comply with SEC rules and reporting requirements.
- The information is structured in XML format, which enhances the ability of analysts and investors to access and analyze the data efficiently.
This summary provides a concise overview of the most pertinent details from the financial report section provided.